Analysts sanguine on Teva despite U.S. court ruling, and sale of satellite operator Spacecom getting closer.
Delek fills its coffers after selling its European filling stations, and Teva plans to inflict pain on the market share of Pfizer's Celebrex drug.
Teva wins approval for generic version of Lovaza.
Husband of Compugen executive accused of using insider information
Partners Ben-Moshe and Elsztain are now talking through their lawyers.
Communications Ministry gives Cellcom draft approval for transfer of control to buyers Ben-Moshe and Elsztain, ending recent speculation.
Plaintiff in class action against Waze for IP violation produces 2006 message from founder of travel app firm to buttress case.
Israeli accountant files lawsuit claiming that Waze stole the intellectual property of a programming community that helped build its software.
Eduardo Elsztain may go it alone or seek new partner, as Communications Ministry investigates Ben-Moshe over potential Cellcom ownership.
MediWound enjoys a great Nasdaq launch, but Babylon licks its wounds after its Q4 profits tumbled.